MEDVi Review: Cost, Care Model and the FDA Warning Letter

What you are actually signing up for with MEDVi

MEDVi sells clinician-guided telehealth across weight loss, men’s health, hair loss and skincare, paid out of pocket rather than through an insurer. Its weight loss line, built around GLP-1 medicines, is why most people run a MEDVi review search in the first place. The company has grown fast and drawn national press attention, and it also carries an FDA warning letter dated February 2026 on the public record. That tension is the whole decision: quick cash-pay access on one side, a live regulatory mark on the other. If you want a provider with a quiet compliance history, this is not that provider, and if you go ahead anyway, get the medicine, the dose, the renewal charge and the cancellation terms in writing before you enter a card.

Is MEDVi legit? Start with the public record

Legitimacy is the first question typed about this company, and the honest answer has two halves. MEDVi is a real operating US telehealth business with a public website, a patient portal and coverage in mainstream and trade press. It also has federal enforcement correspondence against it. Both facts are true, and neither one erases the other.

The February 2026 FDA warning letter

The FDA published a warning letter addressed to MEDVi, LLC, doing business as MEDVi, in February 2026. A warning letter is the agency’s formal written notice that it believes a company has broken federal law, and it asks for correction within a set period. It is not a criminal charge, and it does not close a business. It is still the most serious routine public signal the agency issues short of an injunction or a seizure, and it is the heaviest single fact on this page. Read it yourself rather than taking anyone’s summary: FDA warning letter to MEDVi, LLC.

If you contact the company, ask one direct question: what changed operationally after that letter, and can they show it. A clear, documented answer is meaningful. A vague reassurance is also meaningful, in the other direction. We weight regulatory records heavily rather than treating them as background noise, and you can read how our scoring works to see where that sits.

The May 2025 marketing lawsuit

A federal Telephone Consumer Protection Act case was filed against MEDVi, LLC in May 2025, and trade coverage reports it was later voluntarily dismissed. TCPA claims concern marketing calls and texts, not clinical care, so this is a conduct question rather than a safety one. It still matters practically, because it points at how aggressively the marketing side of a fast-growing telehealth brand may contact you. Read the consent checkboxes at signup, and know that you can withdraw consent to marketing texts and calls at any time under the FCC consumer guidance on unwanted calls and texts.

MEDVi and MEDvidi are two different companies

This trips up almost everyone. MEDvidi is a separate mental health service, and searches about Xanax, Adderall, ADHD prescribing or controlled substances online overwhelmingly point at that company, not this one. MEDVi’s public service lines are weight loss, men’s health, hair loss and skincare. Do not carry a complaint or a compliment from one brand to the other, and check the domain before you type a password: MEDVi accounts sit on medvi.org, while MEDvidi logins sit on medvidi.com. Nothing in MEDVi’s public service description supports treating it as a route to controlled medicines.

How MEDVi bills you, and what to pin down first

MEDVi runs on cash pay. You are the payer, so no claim, referral or deductible stands in the way, and equally no insurer is negotiating the price down on your behalf. What you spend depends on which medicine a clinician prescribes, the dose you settle on, and how many months you stay. Anyone reading a MEDVi review for the money answer should treat month one as an estimate until the second and third charges land. Confirm current pricing on the provider’s site before you sign up, because cash-pay telehealth pricing moves.

The four numbers that decide your real cost

• The monthly medication charge at your starting dose.
• What that charge becomes at a higher dose, since GLP-1 treatment usually steps up.
• Whether any consultation or membership fee bills separately from the medicine.
• What shipping, lab work and follow-up visits add on top.

Ask for all four in one message and keep the reply. A provider that answers plainly has already told you something useful about how it will behave later.

Intro pricing versus the renewal charge

Cash-pay telehealth commonly prices the first month softly and renews higher, and dose escalation can raise the bill again. So compare the month four number against other providers, not the entry number. If a quoted figure only holds for an introductory period, get the renewal figure in writing before you commit. Also ask about refunds: unshipped orders sometimes qualify, while compounded preparations are frequently non-returnable once dispensed.

Twelve months of a cash-pay prescription is a much larger commitment than a monthly figure suggests, so do the annual arithmetic before the first charge rather than after the fourth.

If you want a structured way to compare what you would pay across the category, our free savings report lays out the same cost lines side by side.

The weight loss line: GLP-1 medicines and what they ask of you

This is the track MEDVi is known for, and the one that carries the most clinical weight. Press and industry coverage during 2026 described the business as scaling a GLP-1 weight loss operation quickly, with at least one industry release describing access to compounded semaglutide. Treat that as reporting about the company, not as confirmation of what a clinician will write for you. Establish the exact medicine and its source in your own consultation.

How these medicines work

GLP-1 receptor agonists are incretin-based medicines, meaning they copy a gut hormone released after eating. They slow stomach emptying, reduce appetite and change how full you feel on less food. Tirzepatide acts on two receptors, GLP-1 and GIP. The NIDDK overview of prescription weight management medicines explains where these drugs sit alongside diet, activity and behavioural support, which remain part of the work whichever provider prescribes.

What the trials actually showed

In the STEP 1 trial, adults taking once-weekly semaglutide 2.4 mg lost a mean of about 14.9 percent of body weight over 68 weeks alongside lifestyle support, reported in the NEJM semaglutide obesity trial. In SURMOUNT-1, tirzepatide produced mean reductions up to about 20.9 percent at 72 weeks at the highest dose, published as the NEJM tirzepatide trial results. Those are trial averages under study conditions with structured follow-up. No telehealth provider can promise you the same curve, and any that implies it is overselling.

Compounded or brand-name: settle this before you pay

This single question changes the safety picture, the price and your options if something goes wrong. FDA-approved products come with an approved label and a known manufacturer. Compounded preparations do not go through FDA approval for safety, effectiveness or manufacturing quality, and the agency has documented dosing errors and unapproved forms in the compounded GLP-1 market. See the FDA statement on unapproved GLP-1 drugs and the agency’s compounding questions and answers.

Ask three things and write down the answers: is this the FDA-approved brand or a compounded preparation, which pharmacy fills it, and how is the dose measured in the device you receive. Our guides on semaglutide side effects and compounded versus brand tirzepatide cover what each answer means for you.

Dose titration and follow-up

GLP-1 treatment is not a fixed prescription. Doses start low and step up on a schedule so the gut adjusts, and that schedule is where a telehealth provider either earns its fee or does not. Before paying, confirm how often a clinician reviews you, whether the same clinician stays with your case, how you reach someone between reviews, and whether any baseline or repeat bloodwork is expected. A service that ships a stronger pen every month with no clinical check-in is selling logistics rather than care. Get the follow-up cadence stated explicitly rather than assumed.

Side effects, warnings and who should not take these drugs

Nausea, vomiting, diarrhoea, constipation, reflux and fatigue are the common complaints, and they are usually worst in the days after a dose increase. Serious risks reported in labelling include pancreatitis, gallbladder disease, kidney injury from dehydration caused by prolonged vomiting, and severe low blood sugar when these drugs are combined with insulin or a sulfonylurea. Semaglutide and tirzepatide carry a boxed warning about thyroid C-cell tumours seen in rodent studies, and they are contraindicated in anyone with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome. They are not for use in pregnancy. The FDA’s semaglutide safety information for patients and providers is the primary reference. Contact a clinician promptly for severe or persistent abdominal pain, repeated vomiting, signs of dehydration, or vision changes.

Where you are starting from

Most weight loss services screen on body mass index plus related conditions, so knowing your number before intake tells you how the conversation is likely to go.

For a like-for-like look at how cash-pay GLP-1 services differ on medicine sourcing and follow-up, see the current comparison on our GLP-1 telehealth guide.

Men’s health: convenient, but do not skip the physical basics

Men’s health is one of MEDVi’s advertised lines, and virtual care suits it reasonably well because the history does most of the diagnostic work. Confirm which medicines the clinicians actually prescribe on this track before you assume anything, because catalogues differ between providers and change over time.

The clinical caution matters more than the convenience. Erectile difficulty is frequently an early sign of cardiovascular disease, diabetes or untreated high blood pressure, as MedlinePlus on erectile dysfunction sets out. A questionnaire that never touches your blood pressure, lipids or blood sugar can hand you a prescription while leaving the underlying problem unexamined. If you take nitrates for chest pain, PDE5 inhibitors are dangerous with them and that combination is contraindicated. Tell the prescriber about every medicine and supplement, and get your blood pressure checked in person if it has been a while.

What to confirm on this track

• Which specific molecules the clinician can prescribe, and at what strengths.
• Whether any bloodwork is required or offered before a testosterone-related conversation.
• How refills are authorised, and whether a review is needed to continue.

Hair loss: a long commitment, so the renewal terms matter most

Hair loss treatment is a maintenance category. Benefits build over months and typically fade when treatment stops, which makes the ongoing charge, not the intro charge, the number that decides whether this is worth starting. MedlinePlus on hair loss covers the common patterns and why the cause changes the plan.

Ask what MEDVi’s clinicians prescribe here, and whether it is oral, topical or a combination, because each carries different considerations. Oral finasteride can cause sexual side effects in a minority of men and must not be handled by anyone who is pregnant or may become pregnant, since it can affect a male foetus. Topical minoxidil commonly causes scalp irritation and can shed hair early in treatment before it improves. Sudden patchy loss, scalp scarring or hair loss with other symptoms deserves an in-person examination rather than a photo upload.

Skincare: what a photo-based consultation can and cannot do

Skincare via telehealth works well for common acne and routine anti-ageing prescriptions, and less well for anything that needs to be examined, palpated or biopsied. Photographs compress texture and colour, so a lesion that changes, bleeds or fails to heal belongs in a dermatology clinic, not an app. MedlinePlus on acne outlines the standard treatment ladder.

If a topical retinoid is prescribed, expect dryness, peeling and sun sensitivity in the first weeks, use sun protection, and know that retinoids are avoided in pregnancy. Ask whether the product is an FDA-approved prescription or a compounded blend, because compounded skincare formulas vary between pharmacies and are not reviewed for effectiveness in the way approved products are.

Peptides and longevity products: the part that needs the hardest questions

MEDVi’s own corporate description includes wellness, longevity and peptides alongside its clinical lines. This is the least regulated corner of telehealth and deserves your sharpest scepticism. Many peptides marketed for longevity, recovery or body composition have no FDA approval for those uses, and the FDA has placed a number of peptide substances outside the categories permitted for compounding, as covered in its compounding guidance.

If something in this category is offered to you, ask what it is, what evidence supports the specific claim being made, what legal basis allows it to be compounded and dispensed, and who is monitoring you on it. Unclear answers are a reason to decline, particularly given the enforcement letter already on this company’s record.

MEDVi’s treatment lines at a glance

Signing up: what the process looks like step by step

Step 1: pick the track and start the intake

You choose a service line on the site and begin an online questionnaire. Have your medicines, allergies, past conditions and family history ready, especially thyroid cancer history if you are looking at a GLP-1.

Step 2: confirm your state and give your health details

Telehealth prescribing depends on clinician licensing in the state where you are physically located. Confirm your state is served before you spend time on the form, and expect identity and address checks. Answer the medical questions completely, since a prescription written on incomplete history is the main avoidable risk in any online intake.

Step 3: clinician review

A licensed clinician reviews your intake before anything can be prescribed. Prescription medicines through telehealth always require that evaluation, and no legitimate service skips it. Ask whether the review includes a live conversation or is asynchronous, and whether you can request a video call if you want one.

Step 4: payment, pharmacy and the fine print

Payment is taken from you directly. Before you confirm, check the renewal date, the renewal amount, the cancellation notice period and the refund window, and screenshot the checkout terms. Note which pharmacy is named on the order.

Step 5: delivery, then the first follow-up

Medicine ships to your address, usually with instructions for storage and injection technique where relevant. Diarise your first follow-up rather than waiting to be chased, and log side effects with dates so the next review is based on something better than memory.

Privacy and data practices: what to check yourself

Two different sets of rules usually apply inside one telehealth brand. Your clinical records held by a healthcare provider and its business associates fall under HIPAA. Marketing lists, website analytics, advertising pixels and some app telemetry often sit outside that clinical boundary, governed by the privacy policy rather than health privacy law. Read both documents, because the gap between them is where most surprises live.

Given the 2025 marketing case, pay attention to the consent language at signup. Ask specifically what data is shared with advertising partners, whether you can opt out without losing account access, how to withdraw text and call consent, and how to request deletion of your account and records after cancelling. Ask for the answers by email so you have them in writing. Use a payment method you can dispute, and keep every confirmation message from the portal.

Support, refills and how cancellation really goes

Cash-pay telehealth support is normally portal messaging first, with phone or email as backup. Before signing up, ask what the stated response time is, whether support is available at weekends, and how an urgent clinical question gets escalated to a prescriber rather than answered by a service agent. Refill reliability is the other question worth asking: find out how many days before you run out the next shipment is triggered, and what happens if a pharmacy delays.

On cancellation, the practical advice is the same for every subscription-style medical service. Cancel through the account portal if that route exists, then send a written cancellation message so there is a timestamped record. Check whether notice must land a set number of days before renewal, cancel well ahead of the renewal date rather than on it, and confirm in your bank or card app that the recurring charge has actually stopped. If a charge lands after you cancelled, your written confirmation is what resolves it quickly. Confirm the current cancellation and refund terms with the company directly, since these terms change and they are the ones that bite.

Quick tip: save the cancellation confirmation email in the same folder as your checkout screenshot, so both are in one place if you need them.

Who MEDVi suits, and who should look elsewhere

It makes most sense for a self-paying adult who wants medical weight management or a routine maintenance prescription, has no insurance route worth using, and is comfortable doing the diligence themselves on sourcing, dosing and renewal terms. Someone who will read the pharmacy name, ask whether a preparation is compounded, and diary their own follow-ups can use a service like this sensibly.

Look elsewhere if you want a provider with a clean regulatory file, since the February 2026 warning letter is a legitimate reason to pick a different platform. Also look elsewhere if you need insurance billing, if you have a history of medullary thyroid carcinoma or MEN 2, if you are pregnant or trying to conceive, if your care involves multiple interacting conditions that need coordinated in-person management, or if you are seeking mental health or controlled-substance prescribing, which is not what this company advertises. Browsing our telehealth provider directory is a reasonable next step if the regulatory record is a dealbreaker for you.

Questions to ask MEDVi before you pay

• What changed in your operations after the February 2026 FDA warning letter?
• Is my prescription an FDA-approved product or a compounded preparation, and which pharmacy fills it?
• What is the charge on month two, and at the dose I am likely to reach by month four?
• Does any consultation or membership fee bill separately from the medicine?
• How often will a clinician review me, and can I message a prescriber between reviews?
• What is the cancellation notice period, and what is refundable if an order has not shipped?

If you are moving from another provider, ask that one for a copy of your records and your current dose in writing, check how many days of medicine you hold before you cancel, and time the switch so a titration step does not fall into a supply gap. To sanity-check the total against your current spend, run my numbers with our calculators first.

Reputation check

Public sentiment on this company splits by source, and reading only one side of it gives a distorted picture. The New York Times published an April 2026 feature on how MEDVi’s founders used artificial intelligence to scale a GLP-1 weight loss telehealth business at speed, which is where much of the brand’s mainstream visibility comes from. The trade publication Drug Discovery and Development covered the same stretch from the regulatory side, reporting that the FDA had already warned the company and noting the federal TCPA case filed in May 2025 that was later voluntarily dismissed. That report is here: Drug Discovery and Development on MEDVi and the FDA.

For unfiltered customer comment on billing, delivery and cancellation, the most direct public source is the company’s Trustpilot profile for medvi.org. Read it for patterns in how problems get handled rather than for the headline sentiment. When you search, filter out results about MEDvidi, because that separate company’s reviews dominate several related queries and describe a different service entirely. Community reviews on our own pages are moderated, and any incentivised review is labelled as such.

Educational content, not medical advice. Always consult a qualified clinician before starting, stopping or switching treatment.